Search Results for: MUC1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel C2 complement C2
  • Initial triggering of complement
  • Activation of C3 and C5
  • Regulation of Complement cascade
  • Systemic lupus erythematosus
  • Classic complement pathway component defects, including the following eight diseases: C1q alpha-chain deficiency; C1q beta-chain deficiency; C1q gamma-chain deficiency; C1r deficiency; C1s deficiency; C2 deficiency; C3 deficiency; C4 deficiency
Novel C2CD2L C2CD2 like
Novel C3orf52 chromosome 3 open reading frame 52
Novel CACNG1 calcium voltage-gated channel auxiliary subunit gamma 1
  • Ergocalciferol
  • Enflurane
  • Ibutilide
  • Diltiazem
  • Spironolactone
  • Lercanidipine
  • Nicardipine
  • Verapamil
  • Ethanol
  • Fluspirilene
  • Efonidipine
  • Butamben
  • Bioallethrin
Novel CCDC167 coiled-coil domain containing 167
Novel CD47 CD47 molecule
  • Cell surface interactions at the vascular wall
  • Integrin cell surface interactions
  • Signal regulatory protein family interactions
  • Signal regulatory protein family interactions
  • Neutrophil degranulation
Novel CD53 CD53 molecule
  • Neutrophil degranulation
Novel CD68 CD68 molecule
  • Neutrophil degranulation
Novel CLDN19 claudin 19
  • Tight junction interactions
Novel CLDN6 claudin 6
  • Tight junction interactions
Novel CLDND2 claudin domain containing 2
Novel CMTM7 CKLF like MARVEL transmembrane domain containing 7
Novel COL8A2 collagen type VIII alpha 2 chain
  • Collagen degradation
  • Collagen degradation
  • Collagen biosynthesis and modifying enzymes
  • Assembly of collagen fibrils and other multimeric structures
  • Integrin cell surface interactions
  • Collagen chain trimerization
  • Fuchs corneal dystrophy (FECD); Fuchs endothelial corneal dystrophy
  • Posterior polymorphous corneal dystrophy (PPCD)
Novel CSGALNACT2 chondroitin sulfate N-acetylgalactosaminyltransferase 2
  • CS-GAG biosynthesis
Novel CTNNB1 catenin beta 1
  • Degradation of beta-catenin by the destruction complex
  • Beta-catenin phosphorylation cascade
  • TCF dependent signaling in response to WNT
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Apoptotic cleavage of cell adhesion proteins
  • Deactivation of the beta-catenin transactivating complex
  • Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
  • Ca2+ pathway
  • Adherens junctions interactions
  • Binding of TCF/LEF:CTNNB1 to target gene promoters
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • VEGFR2 mediated vascular permeability
  • Myogenesis
  • Myogenesis
  • Signaling by GSK3beta mutants
  • CTNNB1 S33 mutants aren't phosphorylated
  • CTNNB1 S37 mutants aren't phosphorylated
  • CTNNB1 S45 mutants aren't phosphorylated
  • CTNNB1 T41 mutants aren't phosphorylated
  • RHO GTPases activate IQGAPs
  • Transcriptional Regulation by VENTX
  • InlA-mediated entry of Listeria monocytogenes into host cells
  • RUNX3 regulates WNT signaling
  • Cardiogenesis
  • Germ layer formation at gastrulation
  • Regulation of CDH11 function
  • Regulation of CDH11 function
  • Regulation of CDH19 Expression and Function
  • Regulation of CDH1 Function
  • Degradation of CDH1
  • Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
  • Formation of paraxial mesoderm
  • Formation of axial mesoderm
  • Formation of definitive endoderm
  • Somitogenesis
  • Regulation of MITF-M-dependent genes involved in pigmentation
  • Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
  • Formation of the nephric duct
  • CDH11 homotypic and heterotypic interactions
  • Specification of the neural plate border
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Regulation of PD-L1(CD274) transcription
  • Urea
  • Pilomatricoma; Epithelioma calcificans of Malherbe
  • Gastric cancer
  • Hepatocellular carcinoma
  • Thyroid cancer
  • Colorectal cancer
  • Endometrial Cancer
Novel CTNND1 catenin delta 1
  • Adherens junctions interactions
  • VEGFR2 mediated vascular permeability
  • InlA-mediated entry of Listeria monocytogenes into host cells
  • Regulation of CDH11 function
  • Regulation of CDH11 function
  • Regulation of CDH19 Expression and Function
  • Regulation of CDH1 Function
  • Degradation of CDH1
  • CDH11 homotypic and heterotypic interactions
Novel CTSA cathepsin A
  • MHC class II antigen presentation
  • Sialic acid metabolism
  • Defective NEU1 causes sialidosis
  • Neutrophil degranulation
  • Glycosphingolipid catabolism
  • Galactosialidosis
Novel CXCL16 C-X-C motif chemokine ligand 16
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
Novel CXCL9 C-X-C motif chemokine ligand 9
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
Novel CYB5B cytochrome b5 type B
  • Sphingolipid de novo biosynthesis
  • eNOS activation
  • Phase I - Functionalization of compounds
  • Phenethyl Isothiocyanate

Page 2 out of 16 pages